1,556
Views
1
CrossRef citations to date
0
Altmetric
Research Article

MiR-454-3p promotes apoptosis and autophagy of AML cells by targeting ZEB2 and regulating AKT/mTOR pathway

, , , , , , , , , & show all
Article: 2223874 | Received 20 Sep 2022, Accepted 07 Jun 2023, Published online: 14 Jun 2023

References

  • Thomas D, Majeti R. Biology and relevance of human acute myeloid leukemia stem cells. Blood. 2017;129:1577–1585. doi:10.1182/blood-2016-10-696054
  • Chen X, Xie H, Wood BL, et al. Relation of clinical response and minimal residual disease and their prognostic impact on outcome in acute myeloid leukemia. J Clin Oncol. 2015;33:1258–1264. doi:10.1200/JCO.2014.58.3518
  • Salvatore D, Labopin M, Ruggeri A, et al. Outcomes of hematopoietic stem cell transplantation from unmanipulated haploidentical versus matched sibling donor in patients with acute myeloid leukemia in first complete remission with intermediate or high-risk cytogenetics: a study from the acute leukemia working party of the European society for blood and marrow transplantation. Haematologica. 2018;103:1317–1328. doi:10.3324/haematol.2018.189258
  • Volinia S, Calin GA, Liu CG, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. P Natl Acad Sci. 2006;103:2257–2261. doi:10.1073/pnas.0510565103
  • Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Reviews Cancer. 2006;6:857–866. doi:10.1038/nrc1997
  • Shah NM, Zaitseva L, Bowles KM, et al. NRF2-driven miR-125B1 and miR-29B1 transcriptional regulation controls a novel anti-apoptotic miRNA regulatory network for AML survival. Cell Death Differ. 2015;22:654–664. doi:10.1038/cdd.2014.152
  • Liu Y, Lei P, Qiao H, et al. miR-9 enhances the chemosensitivity of AML cells to daunorubicin by targeting the EIF5A2/MCL-1 axis. Int J Biol Sci. 2019;15:579–586. doi:10.7150/ijbs.29775
  • Ren L, Chen H, Song J, et al. MiR-454-3p-Mediated Wnt/β-catenin signaling antagonists suppression promotes breast cancer metastasis. Theranostics. 2019;9:449–465. doi:10.7150/thno.29055
  • Zhao X, Li X, Zhou L, et al. LncRNA HOXA11-AS drives cisplatin resistance of human LUAD cells via modulating miR-454-3p/Stat3. Cancer Sci. 2018;109:3068–3079. doi:10.1111/cas.13764
  • Ghafouri-Fard S, Abak A, Hussen BM, et al. The emerging role of Non-coding RNAs in pituitary gland tumors and meningioma. Cancers. 2021;13; doi:10.3390/cancers13235987
  • Li H, Mar BG, Zhang H, et al. The EMT regulator ZEB2 is a novel dependency of human and murine acute myeloid leukemia. Blood. 2017;129:497–508. doi:10.1182/blood-2016-05-714493
  • Liao H, Liang Y, Kang L, et al. miR-454-3p inhibits non-small cell lung cancer cell proliferation and metastasis by targeting TGFB2. Oncol Rep. 2021;45; doi:10.3892/or.2021.8018
  • Zuo J, Yu H, Xie P, et al. miR-454-3p exerts tumor-suppressive functions by down-regulation of NFATc2 in glioblastoma. Gene. 2019;710:233–239. doi:10.1016/j.gene.2019.06.008
  • Hui X, Zhang S, Wang Y. miR-454-3p suppresses cell migration and invasion by targeting CPEB1 in human glioblastoma. Mol Med Rep. 2018;18:3965–3972. doi:10.3892/mmr.2018.9386
  • Li X, He S, Ma B. Autophagy and autophagy-related proteins in cancer. Mol Cancer. 2020;19:12. doi:10.1186/s12943-020-1138-4
  • Deng Z, Lim J, Wang Q, et al. ALS-FTLD-linked mutations of SQSTM1/p62 disrupt selective autophagy and NFE2L2/NRF2 anti-oxidative stress pathway. Autophagy. 2020;16:917–931. doi:10.1080/15548627.2019.1644076
  • Klionsky DJ, Abdalla FC, Abeliovich H, et al. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy. 2012;8:445–544. doi:10.4161/auto.19496
  • Li Y, Fei H, Lin Q, et al. ZEB2 facilitates peritoneal metastasis by regulating the invasiveness and tumorigenesis of cancer stem-like cells in high-grade serous ovarian cancers. Oncogene. 2021;40:5131–5141. doi:10.1038/s41388-021-01913-3
  • Kahlert C, Lahes S, Radhakrishnan P, et al. Overexpression of ZEB2 at the invasion front of colorectal cancer is an independent prognostic marker and regulates tumor invasion in vitro. Clin Cancer Res. 2011;17:7654–7663. doi:10.1158/1078-0432.CCR-10-2816
  • Sun M, Wang S, Jiang L, et al. Patulin induces autophagy-dependent apoptosis through lysosomal-mitochondrial axis and impaired mitophagy in HepG2 cells. J Agric Food Chem. 2018;66:12376–12384. doi:10.1021/acs.jafc.8b03922
  • Bernard M, Yang B, Migneault F, et al. Autophagy drives fibroblast senescence through MTORC2 regulation. Autophagy. 2020;16:2004–2016. doi:10.1080/15548627.2020.1713640
  • Wu YT, Tan HL, Shui G, et al. Dual role of 3-methyladenine in modulation of autophagy via different temporal patterns of inhibition on class I and III phosphoinositide 3-kinase. J Biol Chem. 2010;285:10850–10861. doi:10.1074/jbc.M109.080796
  • Maiuri MC, Zalckvar E, Kimchi A, et al. Self-eating and self-killing: crosstalk between autophagy and apoptosis. Nat Rev Mol Cell Biol. 2007;8(9):741–752. doi:10.1038/nrm2239
  • Wang K. Autophagy and apoptosis in liver injury. Cell Cycle. 2015;14(11):1631–1642. doi:10.1080/15384101.2015.1038685
  • Singla S, Iwamoto-Stohl LK, Zhu M, et al. Autophagy-mediated apoptosis eliminates aneuploid cells in a mouse model of chromosome mosaicism. Nat Commun. 2020;11:2958. doi:10.1038/s41467-020-16796-3
  • Bertacchini J, Heidari N, Mediani L, et al. Targeting PI3K/AKT/mTOR network for treatment of leukemia. Cell Mol Life Sci. 2015;72:2337–2347. doi:10.1007/s00018-015-1867-5
  • An Y, Zhang J, Cheng X, et al. miR-454 suppresses the proliferation and invasion of ovarian cancer by targeting E2F6. Cancer Cell Int. 2020;20:237. doi:10.1186/s12935-020-01300-0
  • Lee YS, Dutta A. MicroRNAs in cancer. Annu Rev Pathol. 2009;4:199–227. doi:10.1146/annurev.pathol.4.110807.092222
  • Qian XL, Zhou F, Xu S, et al. MiR-454-3p promotes oxaliplatin resistance by targeting PTEN in colorectal cancer. Front Oncol. 2021;11:638537. doi:10.3389/fonc.2021.638537
  • Bao X, Ren T, Huang Y, et al. Knockdown of long non-coding RNA HOTAIR increases miR-454-3p by targeting Stat3 and Atg12 to inhibit chondrosarcoma growth. Cell Death Dis. 2017;8:e2605. doi:10.1038/cddis.2017.31
  • Shao N, Xue L, Wang R, et al. miR-454-3p is an exosomal biomarker and functions as a tumor suppressor in glioma. Mol Cancer Ther. 2019;18:459–469. doi:10.1158/1535-7163.Mct-18-0725
  • O'Brien J, Hayder H, Zayed Y, et al. Overview of MicroRNA biogenesis, mechanisms of actions, and circulation. Front Endocr. 2018;9:402. doi:10.3389/fendo.2018.00402
  • Bolouri H, Farrar JE, Triche T, Jr. et al. The molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural alterations and age-specific mutational interactions. Nat Med. 2018;24:103–112. doi:10.1038/nm.4439
  • Gu HF, Li HZ, Tang YL, et al. Nicotinate-Curcumin impedes foam cell formation from THP-1 cells through restoring autophagy flux. PloS one. 2016;11:e0154820. doi:10.1371/journal.pone.0154820
  • Zhou P, Xie W, Luo Y, et al. Inhibitory effects of ginsenoside Rb1 on early atherosclerosis in ApoE-/- Mice via inhibition of apoptosis and enhancing autophagy. Molecules-Basel, Switzerland. 2018;23; doi:10.3390/molecules23112912
  • Tashiro SQ, Onodera S, Minami M, et al. Autophagy preceded apoptosis in oridonin-treated human breast cancer MCF-7 cells. Biol Pharm Bull. 2007;30:859–864. doi:10.1248/bpb.30.859
  • Fang S, Wan X, Zou X, et al. Arsenic trioxide induces macrophage autophagy and atheroprotection by regulating ROS-dependent TFEB nuclear translocation and AKT/mTOR pathway. Cell Death Dis. 2021;12:88. doi:10.1038/s41419-020-03357-1
  • Estruch M, Reckzeh K, Vittori C, et al. Targeted inhibition of cooperative mutation- and therapy-induced AKT activation in AML effectively enhances response to chemotherapy. Leukemia. 2021;35:2030–2042. doi:10.1038/s41375-020-01094-0